Results 1 to 10 of about 42,101 (217)
Limiting and controlling carbapenem-resistant Klebsiella pneumoniae
Lisa Saidel-Odes,1,2 Abraham Borer1,21Infection Control and Hospital Epidemiology Unit, 2Infectious Diseases Institute, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, IsraelAbstract ...
Saidel-Odes L, Borer A
doaj +5 more sources
Epidemiological study of carbapenem-resistant Klebsiella pneumoniae
This research is aimed to study the resistance and molecular epidemiological characteristics of carbapenem-resistant Klebsiella pneumoniae (CRKP).
Lin Di +4 more
doaj +3 more sources
Systematic review of carbapenem-resistant Enterobacteriaceae causing neonatal sepsis in China [PDF]
Background Carbapenems are β-lactam antibiotics which are used to treat severe infections caused by multidrug resistant Enterobacteriacea. The recent emergence and rapid spread of Enterobacteriaceae resistant to carbapenems is a global concern.
Yijun Ding +4 more
doaj +3 more sources
Background: Isolates of Klebsiella pneumoniae resistant to Carbapenem appears to be most commonly transmitted by hospitalized patients. This may cause infections which lead to mortality.
Swapna C. Senan +2 more
doaj +1 more source
Elevated Mortality Risk from CRKp Associated with Comorbidities: Systematic Review and Meta-Analysis
Carbapenem-resistant Klebsiella pneumoniae has become a public health problem with therapeutic limitations and high mortality associated with comorbidities.
Lucas Candido Gonçalves Barbosa +4 more
doaj +1 more source
Purpose Carbapenem resistant Klebsiella pneumoniae is associated with nosocomial infections and can cause high mortality, which poses great threat to human health.
Xianzhen Wei +5 more
doaj +1 more source
Reducing dissemination of carbapenem-resistant Klebsiella pneumoniae [PDF]
Besides being resistant to several β-lactams, carbapenem-resistant Klebsiella pneumoniae (CRKP) are often resistant to other widely used antimicrobials such as fluoroquinolones and cotrimoxazole, and sometimes to aminoglycosides (1,2). Although possibly not the only reason, the increased risk of delayed/suboptimal treatment consequent to the multidrug ...
Bassetti, Matteo +1 more
openaire +2 more sources
Pseudomonal ecthyma gangrenosum is a well-known condition in immunosuppressed patients. However, ecthyma gangrenosum associated with Klebsiella pneumoniae is a rare entity that requires early recognition and optimal antibiotic and surgical management. We
Aisha Jamal +4 more
doaj +1 more source
Carbapenem-Resistant Klebsiella pneumoniae Associated with COVID-19 [PDF]
Infections with carbapenem-resistant Enterobacteriaceae are emerging as an important challenge in healthcare settings. Currently, carbapenem-resistant Klebsiella pneumoniae (CRKP) are the species of CRE most commonly encountered in hospitals. CRKP is resistant to almost all available antimicrobial agents, and infections with CRKP have been associated ...
Irina Dumitru +14 more
openaire +3 more sources
Carbapenem resistant Klebsiella pneumoniae is becoming a more significant pathogen because of the grave clinical risk it poses which affects patient’s treatment outcome.
Aminu, B. M.
doaj +1 more source

